TECH stock icon

Bio-Techne
TECH

$71.49
1.22%

Market Cap: $11.3B

 

About: Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Employees: 3,100

0
Funds holding %
of 6,686 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

336% more call options, than puts

Call options by funds: $23.6M | Put options by funds: $5.42M

39% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 49

3% more funds holding

Funds holding: 543 [Q1] → 562 (+19) [Q2]

1% less repeat investments, than reductions

Existing positions increased: 207 | Existing positions reduced: 209

1% less capital invested

Capital invested by funds: $11.3B [Q1] → $11.2B (-$169M) [Q2]

3.56% less ownership

Funds ownership: 102.55% [Q1] → 98.99% (-3.56%) [Q2]

33% less funds holding in top 10

Funds holding in top 10: 6 [Q1] → 4 (-2) [Q2]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$70
2%
downside
Avg. target
$82
15%
upside
High target
$95
33%
upside

3 analyst ratings

positive
67%
neutral
33%
negative
0%
Benchmark
Robert Wasserman
43% 1-year accuracy
16 / 37 met price target
33%upside
$95
Buy
Reiterated
13 Aug 2024
RBC Capital
Conor McNamara
40% 1-year accuracy
14 / 35 met price target
2%downside
$70
Sector Perform
Maintained
8 Aug 2024
Baird
Catherine Schulte
80% 1-year accuracy
8 / 10 met price target
15%upside
$82
Outperform
Maintained
8 Aug 2024

Financial journalist opinion

Based on 5 articles about TECH published over the past 30 days